Posted by Michael Wonder on 07 Jul 2021
Hyalex Orthopaedics receives FDA breakthrough device designation for novel Hyalex cartilage system
7 July 2021 - Hyalex Orthopaedics announced that the Hyalex Cartilage System has been granted breakthrough device designation from the U.S. FDA.
The Hyalex Cartilage System is intended to repair cartilage defects and restore function for patients with loss of knee articular cartilage and bone requiring surgery.
